Written by David Kopp
With peptides emerging as a promising treatment candidate due to their specificity and favorable safety profile, many who struggle with Alzheimer’s disease could expect new treatment options once full research trials have been conducted. If successful, this treatment when administered early could address excess build-ups of beta-amyloid fragments which contribute to memory loss and Alzheimer’s disease itself.
